Aspiring Ventures’s Oracle ORCL Stock Holding History

Aspiring Ventures’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,500	Closed	-$221K	–	112
2026 Q1	$221K	Buy	+1,500	New	+$244K	0.07%	74

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aspiring Ventures's ORCL Position: Q2 2026 in Review

Aspiring Ventures reduced its Oracle (ORCL) stake by 7.2% in Q2 2026, selling an estimated $68K and leaving 4,826 shares worth $707K. The position accounts for 0.17% of the portfolio, ranked #35.

Aspiring Ventures first reported a position in ORCL in Q4 2024 and has held it in 7 quarters since. The position peaked at $847K in Q3 2025. 3,524 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Aspiring Ventures held 4,826 shares of Oracle worth $707K as of Q2 2026.
Aspiring Ventures sold 375 Oracle shares in Q2 2026, an estimated $68K.
Oracle made up 0.17% of Aspiring Ventures's portfolio in Q2 2026, its #35 holding.
Aspiring Ventures first reported a position in Oracle in Q4 2024 and has held it in 7 quarters since.
Aspiring Ventures's Oracle position peaked at $847K in Q3 2025.
3,524 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Aspiring Ventures's 13F filing for Q2 2026, filed 5 Aug 2026.